What Happened?
Cambridge, MA-based Repertoire Resigned Justin McCue as Vice President of Technical Operations
About the Company
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.
About the Person
Justin McCue is Chief Technology Officer at Tscan. Previously, Justin held various senior IT leadership roles in the industry.
Info Source
News
Short Profile